Impact of Global Mean Normalization on Regional Glucose Metabolism in the Human Brain

Because the human brain consumes a disproportionate fraction of the resting body's energy, positron emission tomography (PET) measurements of absolute glucose metabolism (CMRglc) can serve as disease biomarkers. Global mean normalization (GMN) of PET data reveals disease-based differences from...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Neural plasticity. - 1998. - 2018(2018) vom: 19., Seite 6120925
1. Verfasser: Mortensen, Kristian N (VerfasserIn)
Weitere Verfasser: Gjedde, Albert, Thompson, Garth J, Herman, Peter, Parent, Maxime J, Rothman, Douglas L, Kupers, Ron, Ptito, Maurice, Stender, Johan, Laureys, Steven, Riedl, Valentin, Alkire, Michael T, Hyder, Fahmeed
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Neural plasticity
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Glucose IY9XDZ35W2
LEADER 01000naa a22002652 4500
001 NLM28649650X
003 DE-627
005 20231225051835.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1155/2018/6120925  |2 doi 
028 5 2 |a pubmed24n0954.xml 
035 |a (DE-627)NLM28649650X 
035 |a (NLM)30008742 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Mortensen, Kristian N  |e verfasserin  |4 aut 
245 1 0 |a Impact of Global Mean Normalization on Regional Glucose Metabolism in the Human Brain 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.12.2018 
500 |a Date Revised 11.12.2018 
500 |a published: Electronic-eCollection 
500 |a Citation Status MEDLINE 
520 |a Because the human brain consumes a disproportionate fraction of the resting body's energy, positron emission tomography (PET) measurements of absolute glucose metabolism (CMRglc) can serve as disease biomarkers. Global mean normalization (GMN) of PET data reveals disease-based differences from healthy individuals as fractional changes across regions relative to a global mean. To assess the impact of GMN applied to metabolic data, we compared CMRglc with and without GMN in healthy awake volunteers with eyes closed (i.e., control) against specific physiological/clinical states, including healthy/awake with eyes open, healthy/awake but congenitally blind, healthy/sedated with anesthetics, and patients with disorders of consciousness. Without GMN, global CMRglc alterations compared to control were detected in all conditions except in congenitally blind where regional CMRglc variations were detected in the visual cortex. However, GMN introduced regional and bidirectional CMRglc changes at smaller fractions of the quantitative delocalized changes. While global information was lost with GMN, the quantitative approach (i.e., a validated method for quantitative baseline metabolic activity without GMN) not only preserved global CMRglc alterations induced by opening eyes, sedation, and varying consciousness but also detected regional CMRglc variations in the congenitally blind. These results caution the use of GMN upon PET-measured CMRglc data in health and disease 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Glucose  |2 NLM 
650 7 |a IY9XDZ35W2  |2 NLM 
700 1 |a Gjedde, Albert  |e verfasserin  |4 aut 
700 1 |a Thompson, Garth J  |e verfasserin  |4 aut 
700 1 |a Herman, Peter  |e verfasserin  |4 aut 
700 1 |a Parent, Maxime J  |e verfasserin  |4 aut 
700 1 |a Rothman, Douglas L  |e verfasserin  |4 aut 
700 1 |a Kupers, Ron  |e verfasserin  |4 aut 
700 1 |a Ptito, Maurice  |e verfasserin  |4 aut 
700 1 |a Stender, Johan  |e verfasserin  |4 aut 
700 1 |a Laureys, Steven  |e verfasserin  |4 aut 
700 1 |a Riedl, Valentin  |e verfasserin  |4 aut 
700 1 |a Alkire, Michael T  |e verfasserin  |4 aut 
700 1 |a Hyder, Fahmeed  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Neural plasticity  |d 1998  |g 2018(2018) vom: 19., Seite 6120925  |w (DE-627)NLM098558390  |x 1687-5443  |7 nnns 
773 1 8 |g volume:2018  |g year:2018  |g day:19  |g pages:6120925 
856 4 0 |u http://dx.doi.org/10.1155/2018/6120925  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 2018  |j 2018  |b 19  |h 6120925